Syros Pharmaceuticals Inc.

SYRS:NASDAQ

Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches.

streetwise book logo Streetwise Company Fact Sheet

2024/4/24 3:48:00

(SYRS:NASDAQ)

Analyst coverage

H.C. Wainwright & Co.Andrew Fein

Streetwise Reports Articles

12/06/2023 - View Article
05/21/2022 - View Article